z-logo
Premium
Toxoplasmosis and secondary Guillain‐Barré associated with ruxolitinib as graft‐versus‐host disease treatment
Author(s) -
Gonzalez Vicent Marta,
Molina Blanca,
Fabregat María,
Segura María,
Diaz Miguel A.
Publication year - 2019
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.27446
Subject(s) - medicine , disease , ruxolitinib , toxoplasmosis , guillain barre syndrome , host (biology) , graft versus host disease , immunology , pediatrics , myelofibrosis , bone marrow , ecology , biology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom